Obsessive-compulsive disorder in the postpartum: open-label trial of quetiapine augmentation.

OBJECTIVE Postpartum nonpsychotic conditions are routinely treated with antidepressant therapy. However, a subset of this population with comorbid obsessive-compulsive disorder (OCD) is treatment-resistant. Optimal response is obtained by augmentation therapy with novel antipsychotics. The objective of this open-label study was to evaluate clinical response… (More)